47th Annual Meeting of the American-Society-of-Hematology Conference

related documents

• A Novel Inherited Platelet Function Disorder Involving the Thromboxane A2 Pathway of Platelet Activation.  Conferences
• A Novel Thrombin Fluorogenic Substrate of High Affinity, Catalytic Efficiency and Selectivity.  Conferences
• A multicenter, randomized, controlled clinical pilot trial of the feasibility of an intensive RBC transfusion policy for patients with acute leukemia treated with induction chemotherapy or stem cell transplant.  Conferences
• A new model for predicting venesection therapy requirements in hereditary hemochromatosis using non-invasive liver iron concentration measurement  Conferences
• A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.  Conferences
• A revisit of the criteria to define remission in patients with idiopathic thrombocytopenia undergoing splenectomy.  Conferences
• Age significantly influences presentation and patterns of care in patients with newly diagnosed diffuse large cell lymphoma (DLCL): Collective data from 5 centers participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project.  Conferences
• Anti-Xa levels and renal function: Analysis of the first 32 patients in the tinzaparin in renal insufficiency for venous thromboembolism study  Conferences
• Anticoagulant Heparan Sulfate Mediates Antithrombin Amelioration of Leukocyte-Endothelial Interactions in Sepsis.  Conferences
• Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network  Conferences
• Does thromboprophylaxis reduce mortality in medical patients? A systematic review and meta-analysis of randomized controlled tials  Conferences
• Existing warfarin therapy in long-term care facilities maybe inadequate  Conferences
• Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII.  Conferences
• Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: The randomized APOLLO study.  Conferences
• Insights into Disturbed Hemostasis in the Quebec Platelet Disorder Using Thromboelastography, Blood Clots Formed at Low Shear, and Perfusion Studies of Fibrinolysis.  Conferences
• Intravenous gamma globulin does not increase RNA of FcgRIIb in purified human monocytes.  Conferences
• Leukemia-related gene expression of bone marrow cells from patients with Shwachman-Diamond syndrome at the pre-leukemic phase.  Conferences
• Low molecular weight heparin and bleeding in patients with severe renal failure: A meta-analysis  Conferences
• Maintenance therapy with thalidomide/prednisone post autologous stem-cell transplant for patients with multiple myeloma elevates D-dimer and possibly factor VIII levels.  Conferences
• Mechanisms of static and shear-induced platelet adhesion: Differences in the adhesion supported by MMRN1 comparisons with other beta 3 integrin ligands.  Conferences
• MicroRNA Expression Profiling in Sorted AML Subpopulations: A Possible Role for miR-155/BIC in Stem Cell Maintenance and Leukemogenesis.  Conferences
• Notch Activation Converts B Cells into a T Cell Fate at the Earliest Stages of B Cell Committed Progenitors.  Conferences
• Outcomes of previously untreated older patients with multiple myeloma (MM) over time: An analysis of 3 consecutive trials conducted by the NCICCTG, 1983-2003.  Conferences
• Patient Characteristics in CD 20+ and CD 20− Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis.  Conferences
• PedsQL (TM) and EuroQol most responsive measures to change in health-related quality of life in children with Hodgkin's disease.  Conferences
• Pitfalls in interpreting platelet function tests in thrombocytopenic patients referred by a hematologist for diagnostic testing: Results from a single center prospective study.  Conferences
• Potential impact of pathologic review on therapy in non-Hodgkin's lymphoma (NHL): Analysis from the national comprehensive cancer network (NCCN) NHL outcomes project  Conferences
• Pregnancy in thalassemia patients and their partners in a Canadian population.  Conferences
• Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).  Conferences
• Quantitiative Analysis of Roughness of Catheters by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM).  Conferences
• Rates of clinically apparent venous thromboembolism and death resulting from pulmonary embolism among unselected hospitalized acutely ill medical patients versus rates predicted from clinical studies.  Conferences
• Relapse patterns and subsequent outcomes of patients treated on the NCICCTG HD.6 (ECOG JHD06) randomized trial evaluating ABVD alone in patients with limited stage Hodgkin lymphoma (HL).  Conferences
• Rituximab for the treatment of adults with ITP: A systematic review  Conferences
• Sequential analysis of the alpha- and beta-globin gene expressions during erythropoietic differentiation from primate ES cells.  Conferences
• Should high-risk patients with chronic atrial fibrillation and those with coronary artery disease receive combined aspirin-oral anticoagulant therapy or oral anticoagulant therapy alone? A systematic review and meta-analysis  Conferences
• Systematic Review of Randomized Controlled Trials of Prophylactic Clotting Factor Concentrate in Hemophilia.  Conferences
• The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.  Conferences
• The Worcester Venous Thromboembolism Study: A Population Based Perspective of Venous Thromboembolism Attack Rates.  Conferences
• Thrombin Aptamer HD1 Inhibits Prothrombin Activation by Binding Proexosite 1 on Prothrombin.  Conferences
• Thromboembolism in children with sarcoma.  Conferences
• Thromboprophylaxis after orthopaedic surgery with an oral, direct factor Xa inhibitor:: Pooled results of two phase Iib clinical trials.  Conferences
• Towards a conceptual framework for diagnosis of heparin-induced thrombocytopenia (HIT)  Conferences
• Trends in AIDS-Associated Cancers among Patients Attending a Palliative Care Service in Uganda in the ’Pre-HAART’ Era, 1994–2002.  Conferences
• Undetected factor VIII level in a type III von Willebrand disease (vWD) patient masquerading as severe hemophilia  Conferences
• Upper Extremity Deep Vein Thrombosis - Incidence, Risk Factors, and Management. The Worcester Venous Thromboembolism Study.  Conferences
• Use of low dose oral vitamin K in the treatment of patients with INR values of more than 10.0.  Conferences
• VENUS - A study to validate centrally adjudicated venous ultrasound against venography after major orthopaedic surgery.  Conferences
• Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE.  Conferences
• Zinc2+ Promotes Heparin Binding to Fibrin and Subsequent Formation of Ternary Heparin-Thrombin-Fibrin Complexes.  Conferences